Insider Buying: Vitamin Shoppe Inc (VSI) Major Shareholder Buys 300,000 Shares of Stock

Vitamin Shoppe Inc (NYSE:VSI) major shareholder Shah Capital Management bought 300,000 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The stock was bought at an average price of $3.83 per share, for a total transaction of $1,149,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Shah Capital Management also recently made the following trade(s):

  • On Thursday, February 1st, Shah Capital Management bought 5,800 shares of Vitamin Shoppe stock. The stock was bought at an average price of $4.11 per share, for a total transaction of $23,838.00.

Vitamin Shoppe Inc (NYSE VSI) opened at $3.55 on Thursday. Vitamin Shoppe Inc has a twelve month low of $2.95 and a twelve month high of $23.25. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $91.11, a price-to-earnings ratio of -0.33 and a beta of 0.59.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same quarter in the prior year, the firm posted $0.50 EPS. The business’s quarterly revenue was down 8.5% compared to the same quarter last year. analysts expect that Vitamin Shoppe Inc will post 0.34 EPS for the current fiscal year.

Several hedge funds have recently modified their holdings of the company. KBC Group NV grew its holdings in shares of Vitamin Shoppe by 35.0% during the fourth quarter. KBC Group NV now owns 145,501 shares of the specialty retailer’s stock valued at $640,000 after buying an additional 37,715 shares in the last quarter. California Public Employees Retirement System grew its holdings in shares of Vitamin Shoppe by 91.4% during the fourth quarter. California Public Employees Retirement System now owns 269,420 shares of the specialty retailer’s stock valued at $1,185,000 after buying an additional 128,693 shares in the last quarter. Crossmark Global Holdings Inc. grew its holdings in shares of Vitamin Shoppe by 122.8% during the fourth quarter. Crossmark Global Holdings Inc. now owns 31,320 shares of the specialty retailer’s stock valued at $138,000 after buying an additional 17,260 shares in the last quarter. Shah Capital Management grew its holdings in shares of Vitamin Shoppe by 157.9% during the fourth quarter. Shah Capital Management now owns 3,330,000 shares of the specialty retailer’s stock valued at $14,652,000 after buying an additional 2,038,667 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its holdings in shares of Vitamin Shoppe by 106.0% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 667,112 shares of the specialty retailer’s stock valued at $2,936,000 after buying an additional 343,326 shares in the last quarter. Institutional investors and hedge funds own 98.96% of the company’s stock.

A number of equities analysts recently issued reports on the company. Barclays decreased their target price on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a report on Thursday, November 9th. Zacks Investment Research upgraded Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Sunday, January 21st. Morgan Stanley decreased their target price on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a report on Thursday, November 9th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Three research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $5.00.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.com-unik.info/2018/02/08/insider-buying-vitamin-shoppe-inc-vsi-major-shareholder-buys-300000-shares-of-stock.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Insider Buying and Selling by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit